ViGeneron and Daiichi Sankyo enter follow-on collaboration for gene therapy for eye diseases April 26, 2022
Turnstone Biologics collaborates with University of Montreal for development of TIL therapy April 26, 2022
n-Lorem receives funding to support ASO discovery for nano-rare neurodevelopmental diseases April 22, 2022
Codexis and seqWell partner to accelerate commercialization of genomics workflow solutions April 22, 2022
Genequantum collaborates with Aimedbio to develop ADC for brain tumors April 20, 2022 By Doris Yu and Gina Lee Genequantum Healthcare Co. Ltd. will work with Aimedbio Inc. to co-develop an antibody-drug conjugate (ADC) to treat brain and other cancers, working toward an IND filing in 2023. Read More
MJFF grant supports Neuropore's development of TLR2 antagonist for Parkinson's disease April 20, 2022
Ono establishes collaborations to discover small molecules targeting GPCRs in metabolic disease April 20, 2022
RSS